Nuvo Announces 2009 second quarter financi...(Stock-based compensation and payme...),Health

Date:8/7/2009

Stock-based compensation and payments 132 216 264 366 Deferred stock unit expense 145 - 239 - Accretion of interest on debentures 147 227 295 434 Other (273) 91 (257) (261) Net change in non-cash working capital (276) 284 (576) (342) Proceeds from licensing arrangements and advances on research contracts 11,318 - 11,341 - ------------------------------------------------------------------------- CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 9,117 (2,289) 5,951 (5,237) ------------------------------------------------------------------------- INVESTING ACTIVITIES Acquisition of property, plant and equipment (148) (57) (203) (84) Proceeds from sale of assets - - - 28 ------------------------------------------------------------------------- CASH USED IN INVESTING ACTIVITIES (148) (57) (203) (56) ------------------------------------------------------------------------- FINANCING ACTIVITIES Issuance of common shares and warrants, net of related costs 3,246 947 5,442 947 Repayments of long-term debt and capital lease obligations (32) (16) (94) (60) ------------------------------------------------------------------------- CASH PROVIDED BY FINANCING ACTIVITIES 3,214 931 5,348 887 ------------------------------------------------------------------------- Effect of exchange rate changes on cash and cash equivalents (99) (298) (55) (37) ---------------------------------
'/>"/>

SOURCE Nuvo Research Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related medicine news :

1. GeoVax Labs, Inc. Announces Six Month 2009 Financial Results and Provides Operational Update
2. NATB Announces Partnership With Ronald McDonald House Charities(R)
3. LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense
4. ThermoGenesis Announces Launch of Res-Q System; New Device Expands Companys Presence in Bone Marrow Sector
5. Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results
6. AMN Healthcare Announces Second Quarter 2009 Results
7. IRIDEX Announces Second Quarter 2009 Conference Call and Release Date
8. NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions
9. ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program
10. Feline Pine Announces National Take Your Cat to the Vet Day August 22
11. MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock